CiRC Biosciences
Developer of cell-based therapies designed to offer treatments for serious diseases with high unmet needs, with an initial focus on blindness. The company's therapies bypass the need for stem cells by...
Valuation
$0
Share Price
N/A
Total Raised
$39.1M
Last Round
N/A